Abstract: A method is for forming a bioplastic material. The method provides a mixture comprising a keratinaceous substrate, and a secondary biopolymer substrate that includes one or more of an amine, hydroxyl and carboxyl group. The method also includes crosslinking the keratinaceous substrate and the secondary biopolymer substrate to form the bioplastic material. A crosslinking agent may be used.

Abstract: The application is directed to polymer coatings which can be modified to control biointerfacial interactions including biofilm formation and protein adsorption onto said coatings. The polymer coatings comprise a First Component comprising epoxide or alkenyl groups, and a Second Component comprising at least one amine group. The polymer coatings further comprise at least one bioactive agent which may control said biofilm formation and/or protein adsorption. Also disclosed herein are methods for producing said coatings incorporating bioactive molecules in one or two step procedures on a substrate. The polymer coating may be immobilised on the substrate via the reaction of functional groups present on the First Component and/or Second Component with complimentary functional groups disposed on at least one surface of the substrate.

Abstract: The invention disclosed herein relates to compositions for coating a surface to provide a release of antimicrobial active agents from said surface, to coatings formed using said compositions, and to medical devices comprising said coatings.

Abstract: Biodegradable polyether network polymers crosslinked via ester linkages, to substrates, implants and scaffolds including the biodegradable polyether network polymers; methods for preparing such network polymers, implants and scaffolds; and methods of using substrates, implants and scaffolds including the network polymers, particularly for culturing cells and regenerating tissue.

Abstract: The disclosure relates to biodegradable polyether network polymers crosslinked via ester linkages, to substrates, implants and scaffolds comprising the biodegradable polyether network polymers, to methods for preparing such network polymers, implants and scaffolds, and to methods of using substrates, implants and scaffolds comprising the network polymers, particularly for culturing cells and regenerating tissue.

Abstract: The disclosure relates to biodegradable polyether network polymers crosslinked via ester linkages, to substrates, implants and scaffolds comprising the biodegradable polyether network polymers, to methods for preparing such network polymers, implants and scaffolds, and to methods of using substrates, implants and scaffolds comprising the network polymers, particularly for culturing cells and regenerating tissue.